Drugs / prednimustine
prednimustine
also known as
LEO-1031 · NSC-134087 · NSC-171345 · Prednimustina · Prednisolone chlorambucil ester · Sterecyt · Stereocyt
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002905 | Jun 1995 → ? | lymphoma | Centro di Riferimento Oncologico - Aviano | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prednimustine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002905 ↗ |
| Known as | LEO-1031 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | NSC-134087 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | NSC-171345 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | Prednimustina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | Prednisolone chlorambucil ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | Sterecyt | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Known as | Stereocyt | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103751 ↗ |
| Modality | Small molecule | — CHEMBL2103751 ↗ |
| Route | Oral | “oral etoposide and prednimustine on days 1-5” NCT00002905 ↗ |